SciClone Pharmaceuticals, Inc.
(NASDAQ:SCLN)|
0.840 +0.060 (7.69%) Jan 08 - Close |
|
|
|
After-Hours 0.84 0.00 (0.00%) Thu, 8 Jan 2009 7:40 PM
- Compare SCLN with:
- View: Line | Candlestick
Company Profile
SciClone Pharmaceuticals, Inc.
950 Tower Lane
Foster City, CA 94404
United States - Map
Phone: (650) 358-3456
Fax: (650) 358-3469
Website: www.sciclone.com
State of incorporation: Delaware
CEO: Dr. Friedhelm Blobel, Ph.D.
Employees: 200
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Acquisition/development of pharmaceuticals
A biopharmaceutical company engaged in the development and commercialization of therapeutics to treat life-threatening diseases.
Recent news for SCLN
-
SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - Jan 05 at 4:08 ET
-
SciClone investor seeking control of the board
bizjournals.com - Jan 05 at 10:05 ET
-
SciClone Acknowledges Receipt of Director Nomination Notice From Affiliate of Sigma-Tau
Marketwire - Jan 05 at 8:30 ET
-
Marketwire - Dec 22 2008 at 6:30 ET
-
EDGAR Online - Dec 04 2008 at 6:02 ET
-
bizjournals.com - Dec 03 2008 at 11:05 ET
-
SciClone names Gary Titus chief financial officer
AP - Dec 02 2008 at 7:28 ET
-
SciClone Pharmaceuticals names Gary Titus as finance chief
MarketWatch - Dec 02 2008 at 6:42 ET
-
SciClone Pharmaceuticals Appoints Gary Titus as Chief Financial Officer
Marketwire - Dec 02 2008 at 6:30 ET
-
EDGAR Online - Nov 20 2008 at 6:30 ET
